Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells
Authors:
- 7 December 2022
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 83 (4) , 364-375
Abstract
Background: Androgen receptor splice variant (AR‐V) expression has been associated with prostate cancer (PCa) progression to castration‐resistant PCa during androgen deprivation therapy, which reduces androgen production and inhibits androgen action in PCa cells. However, the mechanisms whereby aberrant AR‐V expression is increased in PCa are still largely unknown. Fibroblasts in tumor stroma influence PCa initiation and aggressiveness, and which may play a crucial role in eliciting genetic changes during malignant transformation in human prostate epithelium. Here, our aim was to determine whether prostate fibroblasts in tumor stroma induce aberrant AR‐V7 expression in PCa cells under low androgen concentration.Methods: We performed in vitro experiments using androgen‐sensitive, AR‐positive PCa cell lines (LNCaP and 22Rv1 cells), commercially available prostate stromal cells (PrSC), and primary cultured prostate fibroblasts (pcPrF) from PCa specimens collected from biopsies of patients with advanced PCa. PCa cells were cocultured with each of the three fibroblast lines (PrSC, pcPrF‐M37, and pcPrF‐M48).Results: The proliferation under low androgen concentration of LNCaP and 22Rv1 cells cocultured with PrSC, pcPrF‐M37, or pcPrF‐M48 was significantly increased compared to that of PCa cells cultured alone. Androgen receptor‐full length (AR‐FL) protein expression was increased in LNCaP and 22Rv1 cells cocultured with PrSC, pcPrF‐M37, or pcPrF‐M48. AR‐V7 protein expression was increased in 22Rv1 cells cocultured with PrSC, pcPrF‐M37, or pcPrF‐M48. Under low androgen concentration, AR‐V7 protein expression was slightly detected in LNCaP cells cocultured with PrSC or pcPrF‐M37. Cytokine array analysis revealed that monocyte chemotactic protein‐1 (MCP‐1) and interleukin‐8 (IL‐8) levels in the conditioned medium of 22Rv1 cells cocultured with PrSC, pcPrF‐M37, or pcPrF‐M48 were increased under low androgen concentration. High IL‐8 concentration (30 ng/ml) resulted in significantly increased protein expression of AR‐FL, AR‐V7, and phospho‐NF‐κB p65 in 22Rv1 cells. In contrast, IL‐8 antibody (1 µg/ml) decreased AR‐V7 protein expression in 22Rv1 cells cocultured with PrSC, pcPrF‐M37, or pcPrF‐M48.Conclusions: pcPrF from PCa specimens increase the expression of aberrant AR‐V7 in PCa cells. IL‐8 may be a target for preventing the expression of aberrant AR‐Vs in PCa.Keywords
This publication has 39 references indexed in Scilit:
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular LevelEuropean Urology, 2015
- Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expressionOncogene, 2014
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate CancerNew England Journal of Medicine, 2014
- Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate CancerClinical Cancer Research, 2014
- Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in CancerPharmaceuticals, 2013
- Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate CarcinomaEuropean Urology, 2013
- miR 488* inhibits androgen receptor expression in prostate carcinoma cellsInternational Journal of Cancer, 2010
- Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progressionOncogene, 2006
- Interleukin-8 Induces Nuclear Transcription Factor-κB through a TRAF6-dependent PathwayJournal of Biological Chemistry, 2005
- Cytokine delivery and tissue engineeringYonsei Medical Journal, 2000